You are here

Article Text

Article menu
Download PDFPDF
Industry watch
Tea cigarette: newly emerging smoking product in China
  1. Zidian Xie,
  2. Dongmei Li
  1. Department of Clinical and Translational Research, University of Rochester Medical Center, Rochester, New York, USA
  1. Correspondence to Dr Zidian Xie, Department of Clinical and Translational Research, University of Rochester Medical Center, Rochester, NY 14642-0708, USA; Zidian_Xie{at}urmc.rochester.edu

https://doi.org/10.1136/tc-2023-058341

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Cigarette smoking remains the leading cause of preventable death, with more than 8 million deaths yearly worldwide.1 Tea cigarettes, a type of smoking product promoted as helping people who smoke cigarettes quit and escape nicotine addiction, are gaining increasing popularity on the Chinese market in recent years. Compared with traditional combustible commercial tobacco cigarettes, tea cigarettes replace tobacco with tea leaves. After being lit, the tea releases smoke. Tea cigarette use is often called ‘smoking tea’ or ‘drinking cigarettes’. In January 2020, online sales of tea cigarettes in China reached ¥48.25 million (~US$7 million), an increase of 143% compared with February 2019.2 The level of offline sales of tea cigarettes remains unknown.

    Tea cigarettes in China usually contain tea, chrysanthemum and honey. Chrysanthemum tea as a beverage has many health benefits with diverse biological activities such as antioxidants and anti-inflammatory properties.3 4 Many tea varieties exist in China, such as Pu’er, Golden …

    View Full Text

    Footnotes

    • Contributors ZX and DL conceived the paper, wrote and edited the manuscript.

    • Funding This study was supported by the rapid response project grants from the WNY Center for Research on Flavored Tobacco Products (CRoFT) under cooperative agreement U54CA228110 funded by the National Cancer Institute and US Food and Drug Administration (FDA).

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.